(Q35647781)

9 August 2017

1 reference

title

Vitamin K for the treatment of asymptomatic coagulopathy associated with oral anticoagulant therapy (English)

1 reference

blood coagulation disease

9 August 2017

0 references

1 reference

1 reference

1 reference

Mark A Crowther

1

1 reference

9 August 2017

Sarah Wilson

series ordinal

2

1 reference

9 August 2017

publication date

1 August 2003

1 reference

Journal of Thrombosis and Thrombolysis

9 August 2017

published in

1 reference

9 August 2017

volume

16

1 reference

9 August 2017

issue

1-2

1 reference

9 August 2017

page(s)

69-72

1 reference

The use of oral vitamin K for reversal of over-warfarinization

9 August 2017

cites work

1 reference

12 December 2020

Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities.

1 reference

12 December 2020

Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.

1 reference

12 December 2020

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

12 December 2020

Oral anticoagulation and risk of death: a medical record linkage study

1 reference

12 December 2020

A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin

1 reference

12 December 2020

Treatment of warfarin-associated coagulopathy: a physician survey

1 reference

12 December 2020

Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.

1 reference

12 December 2020

Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.

1 reference

12 December 2020

Risk of major hemorrhage for outpatients treated with warfarin

1 reference

12 December 2020

Retrospective and prospective analyses of the treatment of overanticoagulated patients

1 reference

12 December 2020

Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial

1 reference

12 December 2020

Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione

1 reference

12 December 2020

A survey of oral vitamin K use by anticoagulation clinics

1 reference

12 December 2020

Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.

1 reference

12 December 2020

10.1023/B:THRO.0000014597.87575.E9

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1015554460

0 references

1 reference